Study uncovers mechanisms behind KRAS inhibitor resistance in colorectal cancer
A new preclinical study led by researchers at The University of Texas MD Anderson Cancer Center and Weill Cornell Medicine has uncovered genetic and cell-state adaptive mechanisms that drive resistance…